Price
CHART BY
Historical dividends and forecast
Amgen has so far distributed $5.04 in 2026. The next dividend will be paid on 11.09.2026
$5.461
CHART BY
Frequently asked questions
What is Amgen's market capitalization?
The market capitalization of Amgen is $233.36B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Amgen's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Amgen is 26.81. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Amgen?
Amgen's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $16.10. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Amgen's stock?
Currently, 36 analysts cover Amgen's stock, with a consensus target price of $396.21. Analyst ratings provide insights into the stock's expected performance.
What is Amgen's revenue over the trailing twelve months?
Over the trailing twelve months, Amgen reported a revenue of $38.20B.
Is Amgen paying dividends?
Yes, Amgen is paying dividends. The next payment is scheduled for 11.09.2026, with an expected amount of .
What is the EBITDA for Amgen?
Amgen's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $17.39B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Amgen?
Amgen has a free cash flow of $10.18B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Amgen have, and what sector and industry does it belong to?
Amgen employs approximately 31,500 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Amgen's shares?
The free float of Amgen is 539.32M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $233.36B
- EPS (TTM)
- $16.10
- Free Float
- 539.32M
- P/E ratio (TTM)
- 26.81
- Revenue (TTM)
- $38.20B
- EBITDA (TTM)
- $17.39B
- Free Cashflow (TTM)
- $10.18B
Pricing
- 1D span
- $430.71$440.95
- 52W span
- $269.78$447.01
Analyst Ratings
The price target is $396.21 and the stock is covered by 36 analysts.
Buy
14
Hold
17
Sell
5
Information
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
- Employees
- 31,500
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- Primary Ticker
- AMGN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet